In this time of dire need, Sepragen team is doing its part to solve the problem of COVID-19. We are providing equipment on an expedited basis to a company developing a vaccine for COVID- 19.

Sepragen in the  News

June 2021
Sepragen presents

Sepragen presents at the Annual ACS Conference.

Read more
May 2021
Sepragen wins NIIMBL grant

Sepragen along with SUNY, Albany win NIIMBL grant for “Novel Bioreactor for hematopoietic cell expansion.

Read more
January 2021
Sepragen wins NIIMBL award

Sepragen wins NIIMBL award for “Rapid Continuous Production of Room Temperature Stable mRNA vaccines.

Read more
September 2020
Sepragen ships Custom Chromatography Systems

Sepragen ships two, 125 LPM Custom Chromatography Systems with inline integrated Buffer Blending Capability for Covid-19 vaccine production in 14 weeks to enable ramp from 40M doses to 200M doses/ month.

Read more
September 2019
Sepragen partners with I&L Biosystems

Sepragen partners with I&L Biosystems to distribute it’s products in Europe.

Read more


Click here to read all news and press releases.